Sandra Panem, Ph.D. is a partner of Cross Atlantic Partners, a venture capital firm focused on the emerging life sciences and health care industry. She has 30 years of experience in the life sciences encompassing private and public equity portfolio management, venture capital, scientific research, and public policy. Dr. Panem received a B.S. Degree in Biochemistry and a Ph.D. in Microbiology from the University of Chicago. She was President of Vector Fund Management, a private equity fund investing in the emerging life sciences and healthcare industries. Prior to joining Vector, Dr. Panem served as Vice President and Portfolio Manager for the Oppenheimer Global BioTech Fund, a mutual fund that invested in public and private life science companies. Prior to Oppenheimer, Dr. Panem was Vice President at Salomon Brothers, Inc. where she was a principal member of the investment team responsible for Salomon Brothers Venture Capital. Dr. Panem was also an Assistant Professor of Pathology at the University of Chicago, and a Science and Public Policy Fellow in Economic Studies at the Brookings Institution. She is the author of several books concerning the commercialization of new medical technologies. Dr. Panem has served as a member of numerous Boards of public and private companies, as well as non-profit organizations.